OABI Q2 2023 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M-3.5% YoY

Gross Profit

$2M30.0% margin

Operating Income

-$19M-277.9% margin

Net Income

-$15M-212.0% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-58.9%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$405M

Total Liabilities

$71M

Stockholders' Equity

$334M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$7M	-3.5%
Gross Profit	$2M	$3M	-23.0%
Operating Income	-$19M	-$12M	-55.7%
Net Income	-$15M	-$10M	-43.3%

Revenue Segments

Service

$2M94%

Royalty

$165,0006%